NK cells at the interface between innate and adaptive immunity

Cell Death and Differentiation

Volumn 15, Issue 2, 2008, Pages 226-233

  Moretta, A ^a   Marcenaro, E ^a   Parolini, S ^b   Ferlazzo, G ^c   Moretta, L ^a,d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CYTOKINE; PERFORIN;

ADAPTIVE IMMUNITY; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CYTOKINE PRODUCTION; CYTOTOXICITY; DEGRANULATION; DENDRITIC CELL; EXOCYTOSIS; GENE EXPRESSION REGULATION; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TH1 CELL; UPREGULATION;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL DEGRANULATION; CYTOKINES; CYTOPLASMIC GRANULES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; INFLAMMATION; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTORS;

EID: 38049136577     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402170     Document Type: Review

References (80)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
2. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol 2002; 3: 6-8.
3. Bottino C, Castriconi R, Moretta L, Moretta A. Cellular ligands of activating NK receptors. Trends Immunol 2005; 26: 221-226.
4. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999; 17: 875-904.
5. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19: 197-223.
6. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996; 14: 619-648.
7. Lopez-Botet M, Llano M, Navarro F, Bellon T, NK cell recognition of non-classical HLA class I molecules. Semin Immunol 2000; 12: 109-119.
8. Vilches C, Parham P. KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217-251.
9. Stewart CA, Vivier E, Colonna M. Strategies of natural killer cell recognition and signaling. Curr Top Microbiol Immunol 2006; 298 1-21.
10. Ljunggren HG, Karre K. In search of the 'missing self: MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237-244.
11. Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
12. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Ballet D, Suter M et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999; 5: 405-411.
13. Wilson JL, Heffler LC, Charo J, Scheynius A, Bejarano MT, Ljunggren HG. Targeting of human dendritic cells by autologous NK cells. J Immunol 1999; 163: 6365-6370.
14. Carbone E, Terrazzano G, Ruggiero G, Zanzi D, Ottaiano A, Manzo C et al. Recognition of autologous dendritic cells by human NK cells. Eur J Immunol 1999; 29: 4022-4029.
15. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human denantic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195: 343-351.
16. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchierl G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002; 195: 327-333.
17. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002; 195: 335-341.
18. Moretta A. Natural killer cells and dendrilic cells: Rendezvous in abused tissues. Nat Rev Immunol 2002; 2: 957-964.
19. Zitvogel L. Dendritic and natural killer cells cooperate in the control/ switch of innate immunity. J Exp Med 2002; 195: F9-14.
20. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA. NK cell and DC interactions. Trends Immunol 2004; 25: 47-52.
21. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells: 'l'union fait la force'. Blood 2005; 106: 2252-2258.
22. Gerosa F, Gobbi A, Zorzi P, Burg S, Briere F, Carra G et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 2005; 174: 727-734.
23. Romagnani C, Della Chiesa M, Kohler S, Moewes B, Radbruch A, Moretta L et al. Activation of human NK cells by plasmacytoid dendrttic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. Eur J Immunol 2005; 35: 2452-2458.
24. Marcenaro E, Dondero A, Moretta A. Multi-directional cross-regulation of NK cell function during innate immune responses. Transpl Immunol 2006; 17: 16-19.
25. Moretta A, Marcenaro E, Slvori S, Della Chiesa M, Vitale M, Moretta L. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol 2005; 26: 668-675.
26. Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 1994; 12: 735-773.
27. Trambas CM, Griffiths GM. Delivering the kiss of death. Nat Immunol 2003; 4: 399-403.
28. Perussia B. Fc receptors on natural killer cells. Curr Top Microbiol Immunol 1998; 230: 63-88.
29. Peters PJ, Borst J, Oorschot V, Fukuda M, Krahenbuhl O, Tschopp J et al. Gytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 1991; 173: 1099-1109.
30. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294: 15-22.
31. Bryceson YT, March ME, Barber DF, Ljunggren HG, Long ED. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 2005; 202: 1001-1012.
32. Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 2006; 214: 73-91.
33. Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006; 107: 159-166.
34. Moretta A, Biassoni R, Bottino C, Mingari MC, Moretta L. Natural bytotoxicity recestors that trigger human NK-cell-mediated cytolysis. Immunol Today 2000; 21: 228-234.
35. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Camemolla B et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activatng molecule. J Exp Med 2003; 198: 557-567.
36. Reymond N, Imbert AM, Devilard E, Fabre S. Chabannon C, Xerri L et al DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med 2004; 199: 1331-1341.
37. Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, Hodge MR et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001; 166: 6477-6482.
38. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets, Trends Immunol 2001; 22: 633-640.
39. Vitale M, Della Chiesa M, Carlomagno S, Romagnani C, Thiel A, Moretta L et al. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 2004; 34: 1715-1722.
40. Kawashima D, Oshitani N, Jinno Y, Watanabe K, Nakamura S, Higuchi K et al. Augmented expression of secondary lymphoid tissue chemokine and EB11 ligand chemokine in Crohn's disease. J Clin Pathol 2005; 58: 1057-1063.
41. Ngo VN, Tang HL, Cyster JG. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts nalve T cells and activated B cells. J Exp Med 1998; 188: 181-191.
42. Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA et al The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell lg-like receptors and become cytolytic. J Immunol 2004; 172: 1455-1462.
43. Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity. Blood 2003; 101: 3052-3057.
44. Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, Costa R et al. CD56brightCD16- killer lg-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 2007; 178: 4947-4955.
45. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006; 25: 331-342.
46. Vermi W, Riboldi E, Wittamer V, Gentili F, Luini W, Marrelli S et al Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med 2005; 201: 509-515.
47. Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F et al. The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. Blood 2007.
48. Buentke E, Heffler LC, Wilson JL, Wallin RP, Lofman C, Chambers BJ et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction. J Invest Dermatol 2002; 119: 850-857.
49. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-146.
50. Borg C, Jalil A, Laderach D, Maruyama K, Wakasugi H, Charrier S et al NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004; 104: 3267-3275.
51. Colonna M, Trinchieri G, Liu YJ. Plasmacyloid dendritic cells in immunity. Nat Immunol 2004; 5: 1219-1226.
52. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol 2004; 114: 21-27.
53. Mailliard RB, Son YI, Redlinger R, Coates PT, Giermasz A, Morel PA et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction, of NK cell helper function. J Immunol 2003; 171: 2366-2373.
54. Mocikat R, Braumuller H, Gumy A, Egeter O, Ziegler H, Reusch U et al Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8T cell responses. Immunity 2003; 19: 561-569.
55. Adam C, King S, Allgeier T, Braumuller H, Luking C, Mysliwietz J et al. DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood 2005; 106: 338-344.
56. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 2004; 101: 10116-10121.
57. Ferlazzo G, Morandi B, D'Agostino A, Meazza R, Melioli G, Moretta A et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 2003; 33: 306-313.
58. Sallusto F, Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 1999; 189: 611-614.
59. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 2000; 1: 311-316.
60. Byrne P, McGuirk P, Todryk S, Mills KH. Depletion of NK cells results in disseminating lethal infection with Bordetella perlussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol 2004; 34: 2579-2588.
61. Coudert JD, Coureau C, Guery JG. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4T cell priming and promotes Th type 2 responses to transplantation antigens. J Immunol 2002; 169: 2979-2987.
62. Pende D, Castriconi R, Romagnani P, Spaggiari GM, Marcenaro S, Dondero A et al. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: Relevance for natural killer-dendritic cell interaction. Blood 2006; 107: 2030-2036.
63. Costello RT, Sivori S, Marcenaro E, Lafage-Pochitaloff M, Mozziconacci MJ, Reviron D et al. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 2002; 99: 3661-3667.
64. Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E et al. Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci USA 2005; 102: 2886-2891.
65. Fauriat C, Moretta A, Olive D, Costello RT. Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients. Blood 2005; 106: 2186-2188.
66. Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A; Ortolano S et al Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in-HIV-1 infection. J Exp Med 2006; 203: 2339-2350.
67. Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marcenaro E, Conte R et al. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci USA 2003; 100; 4120-4125.
68. Chiesa MD, Carlomagno S, Frumento G, Balsamo M, Cantoni C, Conte R et al. The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. Blood 2006; 108: 4118-4125.
69. Castriconi R, Dondero A, Cantoni C, Della Chiesa M, Prato C, Nanni M et al. Functional characterization of natural killer cells in type I leukocyte adhesion deficiency. Blood 2007 (in press).
70. Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 2003; 33: 1657-1666.
71. Supajatura V, Ushio H, Nakao A, Akira S, Okumura K, Ra C et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002; 109: 1351-1359.
72. Bennouna S, Bliss SK, Curiel TJ, Denkers EY. Cross-talk in the innate immune system: Neutrophils instruct recruitment and activation of dendritic cells during microbial infection. J Immunol 2003; 171 6052-6058.
73. Bjerke T, Gausladnes M, Nielsen S, Nielsen LP, Schiotz PO, Rudiger N et al. Human blood eosinophils produce and secrete interleukin 4. Respir Med 1996; 90: 271-277.
74. Marcenaro E, Della Chiesa M, Bellora F, Parolini S, Millo R, Moretta L et al. IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J Immunol 2005; 174: 3992-3998.
75. Mailliard RB, Alber SM, Shen H, Watkins SC, Kirkwood JM, Herberman RB et al. IL-18-induced CD83+CCR7+ NK helper cell. J Exp Med 2005; 202: 941-953.
76. Kaser A, Kaser S, Kaneider NC, Enrich B, Wiedermann CJ, Tilg H. Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression. Blood 2004; 103: 648-655.
77. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001; 98: 9237-9242.
78. Della Chiesa M, Romagnani C, Thiel A, Moretta L, Moretta A. Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood 2006; 108: 3851-3858.
79. Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D et al. NKp46 and NKG2D Recognition of Infected Dendritic Cells Is Necessary for NK Cell Activation in the Human Response to Influenza Infection. J Immunol 2007; 178: 2688-2698
80. Vitale M, Della Chiesa M, Carlomagno S, Pende D, Arico M, Moretta L et al. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005; 106: 566-571.